Speakers - 2026

Title: Role of intramuscularly injectable vaccines in the production mechanisms if antybody SIgA

Abstract

Production of antibodies triggers by the natural immune system during infection or through vaccination. For instance, intramuscularly injectable vaccines generally train the body to produce the desiered antibodies. Therefore, in case if a pathogen against which the body trained to produce the antibody invade a tissue, the body (with normal metabolism) starting producing the antibody and through blood stream will be addressed in time and sufficiently to the infected tissue to stop the pathogen before it make the body sick! However, based on our works of 2021 and others, COVID-19 vaccines didn't show the desired result. Because of such uncertainty, we launched an intensive study on “Are Intramuscularly Injectable Vaccines Feasible to stop Respiratory based Pathogens?” that lasted three years (2021-2024). We have analyzed an enormous amount of works: experimental data-meta analysis; clinical case studies; and we used questionnaire as part of the study. As a result, we have formulated six groups of scientific justfications that can serve as tools to evaluate whether intramuscular vaccines are feasible to stop pathogens that affect respiratory tracts. Among them, the less provocative justcation is - identifying the role of injectable vaccines in the production mechanisms of the antibody SIgA within the respiratory organs!  About which we will going to elaborate during the conference events.

The audience take away from presentation:

• Reinforce the ubderstanding if vaccination
• Understanding the correlation: infection-antibody-vaccination
• The audience will use in any issue related to infection vs. prophylaxis-defence
• For the first time we will offer astonishing issue - neglecting the Covid-19 vaccines issues, we will raise doubts on vaccination against Flu, TB, RSV, etc.